Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.09B |
| Enterprise value | 1.96B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.81 |
| Price/book (mrq) | 2.61 |
| Enterprise value/revenue | 5.70 |
| Enterprise value/EBITDA | -13.52 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.26 |
| 52-week change 3 | -13.40% |
| S&P500 52-week change 3 | 18.47% |
| 52-week high 3 | 34.78 |
| 52-week low 3 | 21.57 |
| 50-day moving average 3 | 25.27 |
| 200-day moving average 3 | 27.34 |
Share statistics
| Avg vol (3-month) 3 | 607.8k |
| Avg vol (10-day) 3 | 848.56k |
| Shares outstanding 5 | 137.42M |
| Implied shares outstanding 6 | 137.42M |
| Float 8 | 123.75M |
| % held by insiders 1 | 14.63% |
| % held by institutions 1 | 80.44% |
| Shares short (30 Aug 2023) 4 | 9.09M |
| Short ratio (30 Aug 2023) 4 | 15.06 |
| Short % of float (30 Aug 2023) 4 | 7.86% |
| Short % of shares outstanding (30 Aug 2023) 4 | 6.62% |
| Shares short (prior month 30 Jul 2023) 4 | 8.69M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | -37.42% |
| Operating margin (ttm) | -47.55% |
Management effectiveness
| Return on assets (ttm) | -7.85% |
| Return on equity (ttm) | -12.40% |
Income statement
| Revenue (ttm) | 343.11M |
| Revenue per share (ttm) | 2.59 |
| Quarterly revenue growth (yoy) | 460.40% |
| Gross profit (ttm) | -250.27M |
| EBITDA | -144.6M |
| Net income avi to common (ttm) | -128.38M |
| Diluted EPS (ttm) | -1.09 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.19B |
| Total cash per share (mrq) | 8.67 |
| Total debt (mrq) | 55.52M |
| Total debt/equity (mrq) | 4.68% |
| Current ratio (mrq) | 17.65 |
| Book value per share (mrq) | 8.64 |
Cash flow statement
| Operating cash flow (ttm) | -301.68M |
| Levered free cash flow (ttm) | -265.38M |
© 2023 Yahoo. All rights reserved.
